[1] Menezes EA, Marinho JA, Angelo MR, et al. Isolation and antifungal susceptibility testing of Trichosporon asahii in Ceara, Brazil[J]. Rev Inst Med Trop Sao Paulo, 2012,54(1):1-3.
[2] 杨蓉娅,敖俊红,王文岭,等.阿萨希丝孢酵母引起播散性毛孢子菌病国内首例报告[J].中华皮肤科杂志,2001,34(5):319-332.
[3] Pulvirenti N, Dall'Oglio F, Greco AM, et al. Superflicial cutaneous Trichosporon asahii infection in an immunocompetent host[J]. Int J Dermatol, 2006,45(12):1428-1431.
[4] Yang RY, Wang WL, Ao JH, et al. Pathogenicity of Trichosporon asahii in a murine model of disseminated trichosporonosis[J]. Clin Med J (Engl), 2008,121(24):2557-2560.
[5] Schomig M, Eisenhangdt A, Ritz E. The microinflammatory state of uremia[J]. Blood Purif, 2000, 18(4):327-332.
[6] 万力,杨林,杨芦蓉,等.腹膜透析相关性腹膜炎患者的病原菌分析研究[J]. 中华医院感染学杂志, 2015, 25(5):1022-1024.
[7] Li PK, Szeto CC, Piraino B, et al. Peritoneal dialysis related infections recommendation:2010 update[J]. Perit Dial Int, 2010, 30(4):393-423.
[8] Li PK, Szeto CC, Piraino B, et al. ISPD peritonitis recommendations:2016 update on prevention and treatmen[J]. Perit Dial Int, 2016, 36(5):481-508.
[9] Xia Z, Yang R, Wang W, et al. Genotyping and antifungal drug susceptibility of Trichosporon asahii isolated from Chinese patients[J]. Mycopathologia, 2012,173(2-3):127-133.
[10] Mekha N,Sugita T,Ikeda R,et al. Genotyping and antifungal drug susceptibility of the pathogenic yeast Trichosporon asahii isolated from Thai patients[J]. Mycopathologia, 2010,169(1):67-70.